Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases. (Record no. 12647085)

MARC details
000 -LEADER
fixed length control field 01455 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514073608.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200307s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1756-1833
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1136/bmj.327.7407.147
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Wrenger, Eike
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20030728
245 00 - TITLE STATEMENT
Title Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. BMJ (Clinical research ed.)
Date of publication, distribution, etc. Jul 2003
300 ## - PHYSICAL DESCRIPTION
Extent 147-9 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Acute Kidney Injury
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Angiotensin Receptor Antagonists
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antihypertensive Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diuretics
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Interactions
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Heart Failure
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hyperkalemia
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Spironolactone
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Müller, Regina
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Moesenthin, Michael
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Welte, Tobias
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Frölich, Jürgen C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Neumann, Klaus H
773 0# - HOST ITEM ENTRY
Title BMJ (Clinical research ed.)
Related parts vol. 327
-- no. 7407
-- p. 147-9
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1136/bmj.327.7407.147">https://doi.org/10.1136/bmj.327.7407.147</a>
Public note Available from publisher's website

No items available.